Analyst notes move shares of Hutchmed, Nakanishi, AstraZeneca, and Bayer
Hutchmed's shares rose 3.3% in Hong Kong on Friday after Citi analysts raised the company's stock target following a licensing deal with GSK worth up to $1.295 billion. The same session's batch of healthcare-sector analyst notes also…
2026-09-04 · 3 MIN READ